OVARIAN CANCER SCREENING USING COMPREHENSIVE PROTEOMICS


Year of Award:
2004
Award Type:
R33
Project Number:
CA105295
RFA Number:
PAR-01-104
Technology Track:
Molecular & Cellular Analysis Technologies
PI/Project Leader:
MUDDIMAN, DAVID C.
Other PI or Project Leader:
N/A
Institution:
MAYO CLINIC
The development of biomarkers for earlier detection of ovarian cancer will greatly improve survival. Most women present with advanced stage disease with survival rates of roughly 20%. Advances in the field of proteomics now provide the tools necessary to